Gaithersburg, United States
DxNow, Inc. is at the forefront of simplifying fertility treatments with its innovative sperm separation devices, promoting a patient-centric approach in healthcare. With the slogan, "The future of fertility is simplicity," the company is paving new pathways in biotechnology and healthcare by integrating cutting-edge, portable bio-imaging systems with microfluidic-based consumables.
Founded in 2013, DxNow leverages technologies developed at prestigious institutions such as the Demirci Bio-Acoustic MEMS in Medicine Labs at Harvard Medical School/Brigham & Women’s Hospital and Stanford Medicine. Positioned in Montgomery County, Maryland, their headquarters benefit from a strategic location near key federal agencies like the USFDA and NIH, which aligns well with their business directions.
This privately held Delaware C corporation was last financially backed through an Equity Crowdfunding campaign on August 21, 2015. Despite the absence of disclosed investors in this round, the company's pioneering potential in life sciences continues to be its most compelling investment proposition.
